GlassScriptPhysician profile
Sonya Joseph
NPI 1285242156
$1,113.03
in general payments reported to CMS, 2019-2025
19 companies · $747 in 2025
The $747 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.94 · 2022: $40.22 · 2024: $249 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $262.25 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $132.13 | 2021-2025 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.36 | 2025 | Jardiance |
| Antares Pharma, INC. | $105.49 | 2024-2025 | Xyosted |
| Corcept Therapeutics | $66.33 | 2024-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.03 | 2024-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $53.96 | 2025 | Trelegy Ellipta, Arexvy |
| Phathom Pharmaceuticals, INC. | $50.85 | 2025 | Voquezna |
| Idorsia Pharmaceuticals US INC | $47.42 | 2025 | Quviviq |
| Exact Sciences Corporation | $37.41 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $35.70 | 2021-2025 | |
| Amgen INC. | $27.98 | 2025 | Repatha, Krystexxa |
| Sanofi-Aventis U.S. LLC | $25.17 | 2025 | |
| Optinose US, INC. | $21.12 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.18 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $16.15 | 2024 | |
| Currax Pharmaceuticals LLC | $14.85 | 2025 | Contrave |
| Abbvie INC. | $13.69 | 2025 | |
| Janssen Pharmaceuticals, INC | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.